Evidence map›Paper›PMID 41495677›Full record

ArticleBMC ophthalmology2026

ABCA4-associated maculopathy suspected to be ocular toxoplasmosis.

Maram E A Abdalla Elsayed, Vincenzo Barone, Robert E MacLaren

Abstract readCase Reports
In one paragraph

Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maram E A Abdalla Elsayed *Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 9DU, UK.
Vincenzo Barone *Ophthalmology Complex Operative Unit, University Campus Bio-Medico, Rome, Italy.
Robert E MacLarenOxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 9DU, UK. maram.abdalla@ouh.nhs.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMacular coloboma is a rare congenital anomaly that may mimic other retinal pathologies, including infectious disease and inherited retinal dystrophies. We report a young adult male with longstanding central vision loss and bilateral macular atrophic lesions resembling coloboma, ultimately found to harbour bi-allelic pathogenic variants in ABCA4. CASE PRESENTATION: The patient underwent comprehensive ophthalmologic evaluation, including fundus imaging, optical coherence tomography (OCT), fundus autofluorescence (FAF), molecular genetic analysis, and segregation analysis. Macular dystrophy gene panel sequencing was performed. The patient was followed up for 20 years. OCT confirmed neurosensory retinal and choroidal loss at the fovea. Electro-diagnostics showed cone system dysfunction with preserved rod function. Genetic testing identified compound heterozygosity for two pathogenic ABCA4 variants (c.2160+1G>C and p.Thr1526Met), confirming ABCA4-associated retinopathy

conclusionThis case expands the phenotypic spectrum of ABCA4-related disease to include macular coloboma-like lesions. It also raises the possibility of coexisting retinal pathologies. Genetic testing should be considered in young patients with progressive visual loss and coloboma-like macular lesions, even in the absence of family history or evidence of intraocular inflammation. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

ATP-Binding Cassette TransportersColobomaToxoplasmosis, OcularAdultFluorescein AngiographyFundus OculiHumansMaleTomography, Optical CoherenceVisual AcuityABCA4 protein, humanATP-Binding Cassette TransportersABCA4-associated retinopathyInherited retinal diseasesMacular colobomaMacular dystrophy

Identifiers

PMID41495677
PMCPMC12809953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.